Slide 1: Q1 Report 2025
An entrepreneurial world where people make the difference Bo Annvik, President and CEO Q1 Report 2025 Patrik Johnson, CFO 25 April 2025
Slide 2: Highlights first quarter 2025
Highlights first quarter 2025 ▪ Order intake growth of 5%, organically an increase of 1%, despite the uncertain market situation. Net Sales ‒ Good demand from customers within pharmaceutical production, process industry and energy sector ‒ The majority of companies had organic order intake growth 8.
Slide 3: Organic order intake growth and stable sales
Organic order intake growth and stable sales Order intake Net Sales MSEK MSEK 9,000 30% 9,000 30% 8,000 25% 8,000 25% 20% 20% 7,000 7,000 15% 15% 6,000 6,000 10% 10% 5,000 5,000 5% 5% 4,000 4,000 0% 0% 3,000 -5% 3,000 -5% 2,000 -10% 2,000 -10% 2020 2021 2022 2023 2024 2025 2020 2021 2022 2023 2024 2
Slide 4: Organic sales development Q1 – major countries
Organic sales development Q1 – major countries Nordics Rest of Europe Rest of the world Sweden Benelux North America Denmark UK/Ireland Asia Finland Germany Norway Switzerland & Austria Total Nordics Total Rest of Europe Total Rest of the world 4
Slide 5: Stable EBITA margin
Stable EBITA margin EBITA & EBITA margin Quarterly growth MSEK Q growth 1,400 16% 10% 1,200 15% 8% 6% 5% 1,000 14% 4% 13% 2% 0% 1% 800 0% 12% 0% 600 11% -2% 400 10% -4% -6% 200 9% -8% 0 8% -10% 2020 2021 2022 2023 2024 2025 Organic Acquisitions Divestments Currency Q EBITA Q EBITA margin Q1-25 MARGI
Slide 6: Net Sales by Business Area
Net Sales by Business Area Total growth: 3% 2% +14% 0% -3% ▪ Equal number of working days in the quarter – half of the companies grew organically 8.0% 6.0% 7% ▪ Strong organic sales growth in Business Area Life Science 4.0% ▪ Development mainly driven by sales of equipment Q organic growth for pharm
Slide 7: EBITA margin by Business Area
EBITA margin by Business Area EBITA margin development ▪ Organic sales development and slightly higher expenses are the main drivers of the underlying EBITA margin decline 20% 16.3% ▪ Expenses increase driven by inflation and growth 14.6% initiatives 15% 13.4% 13.5% ▪ Good pricing efforts – record Q
Slide 8: Acquisitions 2025
Acquisitions 2025 Leading German manufacturer specialised in tool technology for mechanical surface treatment Annual Sales: 150 MSEK No employees: 65 Business area: Industrial & Engineering Technical trading company specialised in manufacturing equipment and consumables to the pharmaceutical, medica
Slide 9: Successful acquisition track record
Successful acquisition track record No. of acquired companies per year Quarterly financial effects acquisitions* 18 100 25% 16 90 14 80 20% 70 12 EBITA (MSEK) EBITA margin 60 15% 10 50 8 40 10% 6 30 4 20 5% 2 10 0 0 0% No. of acquired companies No. of acquired companies (3 yr avg) Acquired EBITA Acq
Slide 10: Key data summary
Key data summary MSEK 2025-Q1 2024-Q1 Change R12 2024 Order Intake 8,462 8,037 5% 32,333 31,908 Net Sales 8,036 7,744 4% 32,836 32,544 Gross margin, % 35.4 35.0 35.1 35.0 EBITA 1,094 1,033 6% 4,750 4,689 EBITA-margin, % 13.6 13.3 14.5 14.4 Net financial items -119 -115 3% -510 -506 Tax -185 -177 5%
Slide 11: Strong Cash Flow from operating activities
Strong Cash Flow from operating activities Cash Flow development ▪ All-time-high Q1 operating cash flow in MSEK the quarter of 644 (487) MSEK 1,800 160% 1,600 ▪ Cash flow seasonally low in Q1 140% 1,400 120% ▪ Driven by the higher result and 1,200 100% favorable working capital development 1,000 80%
Slide 12: Earnings per share
Earnings per share EPS development ▪ EPS increased 6% in the quarter to SEK SEK SEK 1.71 (1.61) per share. 2.5 9.0 8.0 ▪ 3- and 5-year rolling 4Q earnings per 2.0 7.0 share CAGR, were 7% and 13% 6.0 1.5 5.0 4.0 1.0 3.0 0.5 2.0 1.0 0.0 0.0 2020 2021 2022 2023 2024 2025 Q EPS R12 EPS 12
Slide 13: Strong financial position
Strong financial position Net debt development ▪ The interest-bearing net debt declined MSEK both sequentially and since same 12,000 100% period last year to SEK 7,721 million 90% 10,000 (8,474) 80% 8,000 70% ▪ The decrease is mainly due to the 60% stronger operational cash flow and the 6,000 50% sl
Slide 14: Key takeaways
Key takeaways ▪ Organic order intake growth despite increased market uncertainty, with positive development in several large customer segments. ▪ Stable sales and profit levels. ▪ Good operational cash flow and strong financial position. ▪ Slightly lower order backlog – many companies are actively w
Slide 15: Thank you!
Thank you! Indutrade
Slide 16: Financial calendar & contact details
Financial calendar & contact details Q2 Report Q3 Report Q4 Report Contact: ir@indutrade.com +46 8 703 03 00
Slide 17: MT indutrade
MT indutrade Trusted by entrepreneurs